Amgen Inc

Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT

Amgen Inc (AMGN) SEC filings

Amgen Inc (AMGN) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 27.4. The AMGN filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Amgen Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

Earnings & events

All events

Event insights for AMGN — what management said, what changed, and why it matters.

No cached SEC filings for AMGN yet. When an 8-K lands, this page will list it.

These filings as JSON? API free 100/day

AMGN SEC filings FAQ

What events are listed on the AMGN SEC page?

Cached event headlines on this Amgen Inc (AMGN) SEC page: "AMGN earnings event"; "AMGN beat EPS estimates (6.29 vs 5.6)". Events: https://lician.com/sec/amgn

What is AMGN's P/E ratio?

Amgen Inc (AMGN) trailing P/E is 27.4 on the latest cached fundamentals snapshot.

What are AMGN's latest revenue and net income?

Latest cached Amgen Inc (AMGN) revenue for Dec 31, 2025 was $36.75B. Net income was $7.71B. Statements: https://lician.com/financials/amgn